U.S. Newborn Screening Policy Dilemmas for the Twenty-First Century
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 74 (1-2) , 64-74
- https://doi.org/10.1006/mgme.2001.3238
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- DNA microarray technology for neonatal screeningActa Paediatrica, 2007
- The Importance of Newborn ScreeningPublished by American Academy of Pediatrics (AAP) ,2000
- Potentials and pitfalls in neonatal screening for type 1 diabetesActa Paediatrica, 1999
- Chemical Amplification: Continuous-Flow PCR on a ChipScience, 1998
- Guidelines for the Retention, Storage, and Use of Residual Dried Blood Spot Samples after Newborn Screening Analysis: Statement of the Council of Regional Networks for Genetic ServicesBiochemical and Molecular Medicine, 1996
- U.S. newborn screening system guidelines: Statement of the council of regional networks for genetic servicesScreening, 1992
- Genotypic Confirmation from the Original Dried Blood Specimens in a Neonatal Hemoglobinopathy Screening ProgramPediatric Research, 1992
- The origin of newborn screeningScreening, 1992
- Newborn Screening for Sickle Cell Disease and Other HemoglobinopathiesJAMA, 1987
- TSH measurements from blood spots on filter paper: A confirmatory screening test for neonatal hypothyroidismThe Journal of Pediatrics, 1976